ZYTOPROTEC

Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major disease areas. The Company was founded by a team of professionals that combine extensive experience in business administration, clinical research, pharmaceutical product development, as well as company and patent law.
ZYTOPROTEC
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
2007-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.zytoprotec.com
Total Employee:
11+
Status:
Active
Contact:
43 1 406 20 02
Email Addresses:
[email protected]
Total Funding:
2 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon SSL By Default HSTS Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
4D pharma Research Ltd
4D pharma Research Limited, a biotechnology company, develops drug compounds from gut bacteria for the prevention.
DorsaVI
DorsaVi is a biotechnology company developing innovative motion analysis device technologies.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Intercytex Group
Intercytex Group is a biotechnology company developing cell-based therapies for the repair and regeneration of skin and hair.
Luciole Medical
Luciole Medical is a Swiss medical technology company developing brain oxygenation monitoring systems.
Mucosis
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
NeuroGeneration
Neurogeneration is a biotechnology company that develops new treatments and products for patients.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Baxter International
Baxter International investment in Series A - Zytoprotec
Official Site Inspections
http://www.zytoprotec.com
- Host name: pl009.a1webhosting.at
- IP address: 193.81.82.82
- Location: Austria
- Latitude: 48.2
- Longitude: 16.3667
- Timezone: Europe/Vienna

More informations about "Zytoprotec"
Zytoprotec - Crunchbase Company Profile & Funding
Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major โฆSee details»
Zytoprotec GMBH / zytoprotec.com
Zytoprotec expects the number of dialysis patients to increase significantly for many years to come. It is estimated that 90% of dialysis fluids contain sugar. The global market for dialysis โฆSee details»
Zytoprotec 2025 Company Profile: Valuation, Funding & Investors
Zytoprotec was founded in 2007. Where is Zytoprotec headquartered? Zytoprotec is headquartered in Vienna, Austria. What is the size of Zytoprotec? Zytoprotec has 10 total โฆSee details»
Zytoprotec Company Profile - Office Locations, Competitors ... - Craft
Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach. It offers PD-protec, a patent-protected solution for peritoneal dialysis (PD). In โฆSee details»
Zytoprotec - Overview, News & Similar companies | ZoomInfo.com
Zytoprotec is a clinical stage life sciences company based in Vienna, Austria. The Company's lead product, PD-protec®, is a patent-protected soluti on for peritoneal dialysis. PD-protec® โฆSee details»
ZYTOPROTEC AT A GLANCE
Zytoprotec started this journey in the field of peritoneal dialysis (PD), one of two forms of dialysis, the other being hemodialysis (HD). Dialysis is a necessary, live-saving procedure for patients โฆSee details»
Zytoprotec GmbH - Life Sciences Directory
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna ... Zytoprotec, a biomedical company founded in 2007, has consistently moved its lead product โ PDprotec® โ โฆSee details»
Zytoprotec - Funding, Financials, Valuation & Investors - Crunchbase
Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How โฆSee details»
Zytoprotec - Crunchbase
Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas. New. Resources. Advanced Search ... Log In. Experience the new โฆSee details»
Zytoprotec GmbH - life-sciences-europe.com
Jan 1, 2007 Zytoprotec is a clinical stage biotechnology company developing drugs exploiting active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that โฆSee details»
Zytoprotec - VentureRadar
Zytoprotec is a clinical stage biotechnology company developing drugs exploiting active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that in โฆSee details»
Zytoprotec GmbH:Company Profile & Technical โฆ
Zytoprotec is a company that provides Health care, Orphan drug, Gastrointestinal agent and more. Zytoprotec is headquartered in Austria Wien. Zytoprotec was founded in 2007. and was โฆSee details»
Key Milestones - zytoprotec.com
Zytoprotec opens first Christian-Doppler-Laboratory (a public-private-partnership) aimed at biomarker research in the field of peritoneal dialysis: 06/2014. Start of double-blinded, placebo โฆSee details»
Zytoprotec - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 25, 2025 Zytoprotec - Develops cytoprotective therapies for the treatment of end-stage renal disease (ESRD) and other diseases. Raised a total funding of $2.9M over 2 rounds from 2 โฆSee details»
Life Sciences Directory: Zytoprotec GmbH
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna ... Zytoprotec, a biomedical company founded in 2007, has consistently moved its lead product โ PDprotec® โ โฆSee details»
Zytoprotec | VentureRadar
Zytoprotec is a clinical stage biotechnology company developing drugs exploiting active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that in โฆSee details»
Zytoprotec - Products, Competitors, Financials, Employees, โฆ
Zytoprotec specializes in advancing peritoneal dialysis within the healthcare sector, focusing on renal replacement therapies. The company's main product, PDprotec, is a novel dialysate โฆSee details»
NEWS & ARCHIVE - zytoprotec.com
The Zytoprotec team is delighted that this was possible despite the difficult financing environment for start-ups during the last two years. And we would like to thank all new investors for the trust โฆSee details»
What is Zytoprotec? Company Culture, Mission, Values
See what employees say it's like to work at Zytoprotec. Salaries, reviews, and more - all posted by employees working at Zytoprotec.See details»
Science & Technology / zytoprotec.com
Zytoprotecโs science and unique therapeutic approach. During evolution, cells of all species have developed and optimized a powerful mechanism to protect against stress. ... S.G. Zarogiannis, โฆSee details»